Reinhart Partners LLC. trimmed its stake in Avantor, Inc. (NYSE:AVTR – Free Report) by 7.7% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 568,329 shares of the company’s stock after selling 47,394 shares during the quarter. Reinhart Partners LLC. owned approximately 0.08% of Avantor worth $7,650,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. Rise Advisors LLC bought a new stake in shares of Avantor during the first quarter valued at about $25,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of Avantor by 288.4% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company’s stock valued at $28,000 after purchasing an additional 1,263 shares in the last quarter. Wealthquest Corp bought a new stake in shares of Avantor during the first quarter valued at about $34,000. GAMMA Investing LLC raised its stake in shares of Avantor by 121.6% during the first quarter. GAMMA Investing LLC now owns 3,747 shares of the company’s stock valued at $61,000 after purchasing an additional 2,056 shares in the last quarter. Finally, Fifth Third Bancorp raised its stake in shares of Avantor by 52.0% during the first quarter. Fifth Third Bancorp now owns 3,972 shares of the company’s stock valued at $64,000 after purchasing an additional 1,359 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors.
Insider Activity at Avantor
In related news, CAO Steven W. Eck sold 3,476 shares of the business’s stock in a transaction that occurred on Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total value of $39,591.64. Following the completion of the sale, the chief accounting officer owned 55,068 shares of the company’s stock, valued at approximately $627,224.52. The trade was a 5.94% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.20% of the company’s stock.
Avantor Stock Up 2.6%
Avantor (NYSE:AVTR – Get Free Report) last posted its quarterly earnings results on Friday, August 1st. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). The company had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.67 billion. Avantor had a return on equity of 11.39% and a net margin of 10.31%.The company’s revenue was down 1.1% compared to the same quarter last year. During the same period last year, the company posted $0.25 earnings per share. On average, equities analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several brokerages have commented on AVTR. Robert W. Baird dropped their price target on shares of Avantor from $18.00 to $15.00 and set an “outperform” rating on the stock in a research report on Monday, August 4th. Barclays reiterated an “overweight” rating and issued a $13.00 price target (down from $15.00) on shares of Avantor in a research report on Monday, August 4th. Stifel Nicolaus set a $12.00 price target on shares of Avantor and gave the stock a “hold” rating in a research report on Monday, August 4th. JPMorgan Chase & Co. dropped their price target on shares of Avantor from $17.00 to $14.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Finally, Raymond James Financial set a $14.00 price target on shares of Avantor and gave the stock an “outperform” rating in a research report on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, Avantor presently has an average rating of “Hold” and an average price target of $15.50.
View Our Latest Research Report on Avantor
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Read More
- Five stocks we like better than Avantor
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Rezolute Stock: FDA Fast Track Fuels 2025 Breakout
- Election Stocks: How Elections Affect the Stock Market
- Is It Time to Trim Your Positions in These 2 AI Stocks?
- What is the Dow Jones Industrial Average (DJIA)?
- These 3 Tech Stocks Just Supercharged Their Buybacks
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.